Takeda selected by major index and sustainability rating institutions concerning Corporate Social Responsibility (CSR)

-       FTSE4Good Global Index (13^th consecutive year)
-       Ethibel Excellence Investment Register (third time)
-       Oekom Prime Status (first time)

Osaka, Japan, July 27, 2017  –  Takeda Pharmaceutical Company Limited (TSE: 4502) announced that it has recently been selected/awarded by multiple global institutions concerning CSR.  The index, the investment universe* and the ratings are shown below;

Name of Index/ InvestmentUniverse*/Ratings	company/ organization	Country	Number of selection
FTSE4Good Global Index	FTSE Russel	UK	13th consecutive year
Ethibel EXCELLENCE Investment Register	Forum Ethibel	BEL	three times
Oekom Prime Status	Oekom	GER	first time

The FTSE4Good Global Index is a benchmark SRI (Socially Responsible Investment)** index provided by FTSE Russell. Ethibel EXCELLENCE Investment Register is a quality mark for investment funds created by Forum Ethibel, a Belgian non-profit organization. Oekom Prime Status is awarded to companies that are among the leaders in environmental and social performance in their industries, which meet industry-specific minimum requirements according to the Oekom Corporate Rating. 

The Index, Investment Register and Sustainability Rating have been some of the most important indices for investors around the world who consider corporate social responsibility (CSR) initiatives of each company when making investment decisions. The selection process consists of reviewing Takeda’s public information such as CSR Databook and other publications. We were selected, on this occasion, in recognition of our active initiatives and information disclosures in the fields of sustainability such as the environment, society and governance.

Focusing on the patients, we believe our activities are the foundation of CSR as a pharmaceutical company committed to creating innovative new drugs. By endeavoring to maintain and enhance healthy business activities and tackling activities that increase the sustainability of society as a good corporate citizen, we practice value-creation and maintenance model. While continuing to work to support and practice Sustainable Development Goals, which are long-term global goals, Takeda will realize its mission, “We strive towards better health for people worldwide through leading innovation in medicine.”

* Investment Universe: A group of corporate brands with similar characteristics that a fund manager can incorporate into an investment portfolio.

** SRI evaluates investments in companies not only in terms of financial performance, but also with an emphasis on corporate social responsibility performance from social, ethical, environmental, and other perspectives.

###